Precancerous lesions of the endometrium: Histologic pattern, classification, prognostic value and therapy;Endometriale hyperplasien: Histologie, klassifikation, prognostische bedeutung und therapie

Zentralblatt fur Gynakologie

Volumn 119, Issue 6, 1997, Pages 251-259

  Horn, L C ^a,b   Bilek, K ^b   Schnurrbusch, Ute ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Atypical complex hyperplasia; Complex hyperplasia; Doppler sonography; Endometrial carcinoma; Hysteroscopy; Precancerous lesions; Simple hyperplasia; Transvaginal sonography

Indexed keywords

ARTICLE; DISEASE CLASSIFICATION; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; PROGNOSIS; UTERUS SURGERY;

ADENOCARCINOMA; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENDOSONOGRAPHY; FEMALE; HUMANS; HYSTEROSCOPY; PRECANCEROUS CONDITIONS; PROGNOSIS;

EID: 0030879099     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Achiron R, Liptiz S, Sivan E, Goldemberg M, Horovitz A, Frenkel Y, Mashiach S: Changes mimicking endometrial neoplasia in postmenopausal, tamoxifen - treated women with breast cancer: A transvaginal doppler study. Ultrasound Obstet Gynecol 6 (1995) 116-120
2. Ausems EWMA, Kamp JK van der, Baak JPA: Nuclear morphometry in the determination of the prognosis of marked atypical endometrial hyperplasia. Int J Gynecol Pathol 4 (1985) 180-185
3. Baak JPA, Wisse-Brekelmans ECM, Fleege JC, Putten HWHM van der, Bezemer PD: Assessment of the risk on endometrial cancer in hyperplasia by means of morphological and morphometrical features. Pathol Res Pract 188 (1992) 856-859
4. Boring CC, Squires TS, Tong S: Cancer statistics: 1993. CA Cancer J Clin 43 (1993) 7-26
5. Brustmann H, Riss P, Naudé S: Nucleolar organizer regions as markers of endometrial proliferation: A study of normal, hyperplastic and neoplastic tissue. Hum Pathol 26 (1995) 664-667
6. Carmichael PL, Ugwumadu AH, Neven P, Hewer AJ, Poon GK, Phillips DH: Lack of genotoxicity of tamoxifen in human endometrium. Cancer Res 56 (1996) 1475-1479
7. Carter JR, Lau M, Saltzman AK, Hartenbach EM, Chen MD, Johnson PR, Fowler JM, Carlson JW, Carson LF, Twiggs LB: Gray scale and color flow Doppler characterisation of uterine tumors. J Ultrasound Med 13 (1994) 835-840
8. Casper RF: Regulation of estrogen/progestogen receptors in the endometrium. Int J Fertil 41 (1996) 16-21
9. Casslén B, Urano S, Ny T: Progesterone regulation of plasminogen activator inhibitor 1 (PAI-1) antigen and mRNA levels in human endometrial stromal cells. Thrombosis Res 66 (1992) 75-87
10. Chan FY, Chau MT, Pun TC, Lam C, Ngan HY, Leong L, Wong RL: Limitations of transvaginal sonography and color Doppler imaging in the differentation of endometrial carcinoma from benign lesions. J Ultrasound Med 13 (1994) 623-628
11. Clement PB: Pathology of the uterine corpus. Hum Pathol 22 (1991) 776-791
12. Consocenti G, Meir YJ, Fischer-Tamaro L, Maieron A, Natale R, D'Ottavio G, Rustico M, Mandruzzato G: Endometrial assessment by transvaginal sonography and histological findings after D&C in women with postmenopausal bleeding. Ultrasound Obstet Gynecol 6 (1995) 108-115
13. Consocenti G, Meir YJ, Fischer-Tamaro L, Maieron A, Natale R, D'Ottavio G, Rustico M, Facca MC, Monterosso A, Mandruzzato G: The diagnostic capacities of transvaginal echography and hysteroscopy in the charaterisation of endometrial pathology. Minerva Ginecol 47 (1995) 293-300
14. Dallenbach-Hellweg G, Schmidt-Matthiessen H: Hyperplasien, Präkanzerosen und Karzinome des Endometrium. Pathologe 5 (1984) 58-59
15. Dallenbach-Hellweg G: The endometrium of infertility. Pathol Res Pract 178 (1984) 527-537
16. Dallenbach-Hellweg G: Histopathology of the endometrium. Berlin-Heidelberg-New York: Springer 1987
17. Dallenbach-Hellweg G: Die neue cytogenetische Klassifikation der Präcancerosen und Carcinome des Endometrium: Möglichkeiten und Grenzen der immunhistochemischen Differenzierung. Verh Dtsch Ges Pathol 75 (1991) 357-362
18. Dallenbach-Hellweg G: Endometrial carcinomas. In: Current Topics in Pathology. Vol. 85. Ed.: Sasano N. Berlin-Heidelberg: Springer 1992, 1-34
19. Dallenbach-Hellweg G, Hahn U: Mucinous and clear cell adenocarcinomas of the endometrium in patients receiving antiestrogens (Tamoxifen) and gestagen. Int J Gynecol Pathol 14 (1995) 7-15
20. Dallenbach-Hellweg G, Hahn U, Schmidt D: Morphologische Endometriumveränderungen unter Tamoxifen. Zentralbl Gynakol 118 (1996) 365-369
21. DiSaia PJ, Creasman WT (Eds.): Adenocarcinoma of the uterus. In: Clinical Oncology. St. Luis: Mosby 1993, 156-193
22. Furr BJA, Jordan VC: The pharmacology and clinical uses of tamoxifen. Pharmacol Ther 25 (1984) 127-205
23. Göretzlehner G, Lauritzen C: Praktische Hormontherapie in der Gynäkologie. Berlin: de Gryter 1992, 272
24. Giudice LC: Growth factors and growth modulators in human uterine endometrium: Their potential relevance to reproductive medicine. Fertil Steril 61 (1994) 1-17
25. Hendrickson MR, Kempson RL: Endometrial epithelial metaplasias. Proliferations frequently misdiagnosed as adenocarcinoma: Report of 89 cases and proposed classification. Amer J Surg Pathol 4 (1980) 525-542
26. Hendrickson MR, Ross JC, Kempson RL: Toward the development of morphologic criteria for well differentiated adenocarcinoma of the endometrium. Amer Surg Pathol 7 (1983) 819-838
27. Horn LC, Fricke K, Krugmann J: Histologische Klassifikation und morphologische Prognosefaktoren bei malignen Ovarial-Tumoren. Zentralbl Gynakol 117 (1995) 335-345
28. Ismail SM: Pathology of endometrium treated with tamoxifen. J Clin Pathol 47 (1994) 827-833
29. Kaku T, Tsukamoto N, Tsuruchi N, Sugihara K, Kamura T, Nakano H: Endometrial metaplasias associated with endometrial carcinoma. Obstet Gynecol 80 (1992) 812-816
30. Karlsson B, Granberg S, Hellberg P, Wikland M: Comparative study of transvaginal sonography and hysteroscopy for the detection of pathologic endometrial lesions in women with postmenopausal bleeding. J Ultrasound Med 13 (1994) 757-762
31. Karlsson B, Granberg S, Wikland M, Ylöstalo P, Torvid K, Marsal K, Valentin L: Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - A nordic multicenter study. Amer J Obstet Gynecol 172 (1995) 1488-1494
32. Kedar RP, Bourne TH, Rowles TJ, Collins WP, Ashley SE, Cosgrove DO, Campbell S: Effects of tamoxifen on uterus and ovaries of postmenopausal women in a randomised breast cancer prevention trial. Lancet 343 (1994) 1318-1321
33. Kosary CL: FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: An analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva and vagina. Sem Surg Oncol 10 (1994) 31-46
34. Kurman RJ, Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 49 (1982) 2547-2559
35. Kurman RJ, Kaminski PF, Norris HJ: The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 56 (1985) 403-412
36. Kurman RJ, Mazur MT: Benign diseases of the endometrium. In: Blaustein's Pathology of the Female Genital Tract. Hrsg.: Kurman RJ. New York-Berlin-Heidelberg: Springer 1994, 367-410
37. LeRoy X, Escot C, Brouillet JP: Decrease of c-erbB-2 and c-myc RNA in tamoxifen-treated breast cancer. Oncogene 6 (1991) 431-437
38. Longacre TA, Chung MH, Jensen DN, Hendrickson MR: Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. Amer J Surg Pathol 19 (1995) 371-406
39. Milde-Langosch K, Riethdorf L, Löning T: Biologischer Stellenwert von viralen Infektionen und Onkogenen/Tumorsuppressorgenen bei Uteruskarzinomen. Verh Dtsch Ges Zytol 19 (1995) 115-124
40. Monk BJ, Chapman JA, Johnson GA, Brightman BK, Wilczynski SP, Schell MJ, Fan H: Correlation of C-myc and HER-2/neu amplification and expression with histopathologic variables in uterine corpus cancer. Amer J Obstet Gynecol 171 (1994) 1193-1198
41. Nephew KP, Polek TC, Khan SA: Tamoxifen-induced proto-oncogene expression persists in uterine endometrial epithelium. Endocrinology 137 (1996) 219-224
42. Norris HJ, Tavassoli FA, Kurman RJ: Endometrial hyperplasia and carcinoma. Amer J Surg Pathol 7 (1983) 839-847
43. Nyholm HCJ, Nielsen AL, Lyndrup JL, Norup P, Thorpe SM: Biochemical and immunohistochemical estrogen and progesteron receptors in adenomatous hyperplasia and endometrial carcinoma: Correlations with stage and other clinicopathologic features. Amer J Obstet Gynecol 167 (1992) 1334-1342
44. Pesch B, Halekoh U, Ranft U, Richter M, Pott F: Atlas zur Krebssterblichkeit in Nordrhein-Westfalen. Ministerium für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen, Düsseldorf: Eigenverlag 1994
45. Read LD, Keith D, Slamon DJ, Katzenellenbogen BS: Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p 185 protein expression in human breast cancer cell lines. Cancer Res 50 (1990) 3947-3951
46. Riethdorf L, Begemann C, Milde-Langosch K, Löning T: p53 Mutationen in normalem Endometrium, endometrialen Hyperplasien und Endometriumkarzinom. Verh Dtsch Ges Pathol 79 (1995) 495
47. Rüschoff J, Barth P: Theorie und Praxis der Silberfärbung Nukleolus organisierender Regionen (AgNOR). Pathologe 13 (1991) 13-19
48. Samsioe G: Hormone replacement therapy: Aspects of bleeding problems and compliance. Int J Fertil 41 (1996) 11-15
49. Schmidt-Matthiessen H, Bastert G: Gynäkologische Onkologie. Stuttgart: Schattauer 1993, 46
50. Sherman ME, Bitterman P, Rosansheim NB, Delgado G, Kurman RJ: Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features. J Surg Pathol 16 (1992) 600-610
51. Shweiki D, Itin A, Neufeld G: Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 91 (1993) 2235-2243
52. Silverberg SG, Kurman RJ: Tumors of the uterine corpus and gestational trophoblastic disease. AFIP-Atlas Third series Fasc. 3 (1992) 18-33
53. Tavassoli F, Kraus FT: Endometrial lesions in uteri resected for atypical endometrial hyperplasia. Amer J Clin Pathol 70 (1978) 770-779
54. Thornton JG, Wells M: Oestrogen receptor in glands and stroma of normal and neoplastic human endometrium: A combined biochemical, immunohistochemical and morphometric study. J Clin Pathol 40 (1987) 1437-1442
55. Welsh AO: Uterine cell death during implantation and early implantation. Microscop Res Technique 15 (1993) 223-245
56. Wilkinson N, Buckley CH, Chawner L, Fox H: Nucleolar organiser regions in normal, hyperplastic and neoplastic endometrium. Int J Gynecol Pathol 9 (1990) 55-59
57. Wulf K-H, Schmidt-Matthiessen H: Spezielle gynäkologische Onkologie I. In: Klinik der Frauenheilkunde und Geburtshilfe, Bd. 11. München-Wien-Baltimore: Urban & Schwarzenberg 1991, 230